Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19
2024 · Clinical Infectious Diseases · 10 citations
https://doi.org/10.1093/cid/ciae529
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
253
Citations
8
h-index
6
i10-index
Abigail Sloan is an academic researcher from Pfizer (United States). The author has contributed to research in topics: melanin and skin pigmentation & Vitamin D Research Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 8, co-authored 17 publications.
ORCID: 0000-0003-0567-1949Click to start Chat